NIH-funded research R01 grant

Understanding Gout and High Uric Acid Through Body Chemistry and Gut Bacteria

Official title: NOVEL METABOLITE AND MICROBIOTA PATHWAYS FOR HYPERURICEMIA AND GOUT

Funded at Massachusetts General Hospital · NIH-11064865 · Data updated 2026-11-12

This project aims to understand how body chemistry and gut bacteria contribute to high uric acid and gout, a painful form of arthritis.

More Microbiota research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startSeptember 20, 2013
Project endFebruary 28, 2027
Funding year2025
Award (this year)$639,196
NIH project number5R01AR065944-09
Project IDNIH-11064865 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for future related studies might include adults aged 21 and older, particularly those with hyperuricemia or gout, including African American individuals.

Less likely to help

Patients who do not have hyperuricemia or gout, or those not interested in research focused on metabolic and microbial pathways, may not directly benefit from this specific research.

What this research studies

Gout is a painful type of arthritis caused by too much uric acid in the body, and it's becoming more common globally. While we know lifestyle and genes play a role, it's still unclear why some people with high uric acid get gout and others don't, and why men are more affected than women. This work looks closely at the body's natural chemicals (metabolites) and gut bacteria to uncover new ways they might influence gout development and inflammation. By exploring these connections, we hope to find better ways to predict, prevent, and treat this condition.

Why it matters

Potential benefit: If successful, this work could lead to new ways to predict who will develop gout, prevent its progression, and develop more effective treatments by targeting specific body chemicals or gut bacteria.

How similar studies have gone: While the specific combination of metabolite and microbiota pathways for gout is novel, previous research has successfully identified genetic and lifestyle risk factors for gout.

Where this research is happening

  • Massachusetts General Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Choi, Hyon K — Massachusetts General Hospital
  • Study coordinator: Choi, Hyon K

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.